Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies
Monday, June 15, 2026 1 min read
Key Takeaway: The article discusses the presentation of results from two large prospective studies on endogenous hypercortisolism in patients with resistant hypertension and difficult-to-control type 2 diabetes. The findings were presented by Dr. Ralph DeFronzo at the Endocrine Society Annual Meeting in Chicago. This research highlights important health implications for managing these conditions.
Price reaction · baseline $83.16 (2026-06-15T17:00:00.000Z) · hit during market hours · 4 other CORT headline(s) in the window, move may be shared
day 0 close · peak
0%
Market Sentiment Analysis
POSITIVE FACTORS
Presentation of significant findings at a major conference.
Focus on a critical health issue affecting diabetes and hypertension.
Involvement of a reputable presenter, Dr. Ralph DeFronzo.
Full Press Release Details
Presented : Endocrine Society (ENDO) Annual Meeting, 15 June 2026, Chicago, IL
Presenter : Ralph DeFronzo, MD
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.
Download Poster
The post Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies appeared first on Corcept Therapeutics .
Frequently Asked Questions
What was presented at the Endocrine Society Annual Meeting?
Results from two large prospective studies on endogenous hypercortisolism.
Who presented the findings at the conference?
Dr. Ralph DeFronzo presented the findings.
What conditions were studied in the research?
The study focused on resistant hypertension and difficult-to-control type 2 diabetes.